New drug duo tested for Tough-to-Treat pancreatic cancer
Disease control
Completed
This study tested whether combining two drugs, pembrolizumab (an immunotherapy) and azacitidine, could help control advanced pancreatic cancer that had worsened after initial chemotherapy. All 36 participants received the drug combination. The goal was to see if this new approach…
Phase: PHASE2 • Sponsor: Susan E. Bates • Aim: Disease control
Last updated Apr 01, 2026 23:41 UTC